We are live on
!
Find out more
NA
NewEdge Advisors Portfolio holdings
AUM
$27.7B
1-Year Est. Return
22.98%
This Fund
S&P 500
This Quarter
Est. Return
+6.1%
1 Year Est. Return
+22.98%
3 Year Est. Return
+69.07%
5 Year Est. Return
+86.55%
10 Year Est. Return
+264.51%
AUM
$8.85B
AUM Growth
+$851M
(+11%)
Cap. Flow
+$412M
Cap. Flow
% of AUM
4.65%
Top 10 Holdings %
Top 10 Hldgs %
16.84%
Holding
3,702
New
289
Increased
1,323
Reduced
1,138
Closed
218
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$30.8M |
| 2 |
Unilever
UL
|
+$28.5M |
| 3 |
Comcast
CMCSA
|
+$27.6M |
| 4 |
Illinois Tool Works
ITW
|
+$27.1M |
| 5 |
Mondelez International
MDLZ
|
+$26.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$30.6M |
| 2 |
Abbott
ABT
|
+$28.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$27.8M |
| 4 |
Dover
DOV
|
+$27.1M |
| 5 |
State Street Ultra Short Term Bond ETF
ULST
|
+$24.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.26% |
| 2 | Financials | 5.78% |
| 3 | Healthcare | 5.7% |
| 4 | Consumer Discretionary | 4.46% |
| 5 | Industrials | 3.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ME
3051
DELISTED
23andMe Holding Co
ME
| $2.31K | ﹤0.01% |
66
| – | – |
|
|
CRON
3052
Cronos Group
CRON
$1.08B
| $2.3K | ﹤0.01% |
1,167
-411
| -26% | -$752 |
|
|
DHIL
3053
DELISTED
Diamond Hill
DHIL
| $2.29K | ﹤0.01% |
13
-12
| -48% | -$2K |
|
|
OPLN
3054
Openlane
OPLN
$4.29B
| $2.28K | ﹤0.01% |
150
| – | – |
|
3055
Sensient Technologies
SXT
$5.28B
| $2.28K | ﹤0.01% |
+32
| New | +$2.38K |
|
3056
Kura Oncology
KURA
$826M
| $2.27K | ﹤0.01% |
215
| – | – |
|
|
AIV
3057
Aimco
AIV
$383M
| $2.26K | ﹤0.01% |
265
+216
| +441% | +$1.76K |
|
3058
ESS Tech
GWH
$22.3M
| $2.25K | ﹤0.01% |
102
+100
| +5,000% | +$1.81K |
|
3059
First Guaranty Bancshares
FGBI
$158M
| $2.25K | ﹤0.01% |
200
| – | – |
|
3060
Texas Roadhouse
TXRH
$13.7B
| $2.25K | ﹤0.01% |
20
| – | – |
|
3061
Theravance Biopharma
TBPH
$873M
| $2.25K | ﹤0.01% |
+217
| New | +$2.4K |
|
3062
State Street SPDR FactSet Innovative Technology ETF
XITK
$68.5M
| $2.25K | ﹤0.01% |
17
| – | – |
|
3063
Freshpet
FRPT
$2.98B
| $2.24K | ﹤0.01% |
+34
| New | +$2.23K |
|
3064
RenaissanceRe
RNR
$13.2B
| $2.24K | ﹤0.01% |
12
-73
| -86% | -$14.5K |
|
3065
Beam Global
BEEM
$23.1M
| $2.24K | ﹤0.01% |
216
+200
| +1,250% | +$2.19K |
|
3066
Actinium Pharmaceuticals
ATNM
$26.3M
| $2.23K | ﹤0.01% |
+300
| New | +$2.55K |
|
3067
iShares MSCI Spain ETF
EWP
$2.11B
| $2.23K | ﹤0.01% |
77
| – | – |
|
3068
Donegal Group Class A
DGICA
$732M
| $2.21K | ﹤0.01% |
153
-37
| -19% | -$547 |
|
3069
Celestica
CLS
$40.5B
| $2.21K | ﹤0.01% |
+152
| New | +$1.88K |
|
3070
Host Hotels & Resorts
HST
$17.2B
| $2.21K | ﹤0.01% |
131
+84
| +179% | +$1.41K |
|
3071
PDS Biotechnology
PDSB
$39.1M
| $2.15K | ﹤0.01% |
+427
| New | +$2.8K |
|
3072
Symbotic
SYM
$5.46B
| $2.14K | ﹤0.01% |
+50
| New | +$1.64K |
|
3073
Ranger Energy Services
RNGR
$363M
| $2.14K | ﹤0.01% |
+209
| New | +$2.34K |
|
3074
Scholastic
SCHL
$789M
| $2.13K | ﹤0.01% |
55
+1
| +2% | +$39 |
|
3075
Bio-Techne
TECH
$11.2B
| $2.12K | ﹤0.01% |
26
+6
| +30% | +$482 |
|
Similar funds
FDCDDQ
TWC
N
PCH
PAM
NewEdge Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, NewEdge Advisors held 3,702 positions worth $8.85B, up 11% from $8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
NewEdge Advisors deployed $412M of net new capital in Q2 2023, opening 289 new positions and adding to 1,323 existing holdings. Its largest new stake was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Accenture, an estimated $30.6M trimmed.
- NewEdge Advisors's largest Q2 2023 buy was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.
- NewEdge Advisors added most to AbbVie in Q2 2023, an estimated $30.8M increase.
- NewEdge Advisors's biggest Q2 2023 reduction was Accenture, cutting an estimated $30.6M.
- NewEdge Advisors fully exited Quadratic Deflation ETF in Q2 2023, selling an estimated $3.13M.
- NewEdge Advisors's ten largest holdings make up 17% of its $8.85B portfolio in Q2 2023.
- NewEdge Advisors opened 289 new positions and closed 218 in Q2 2023.
- NewEdge Advisors's portfolio value rose 11% quarter-over-quarter to $8.85B.
Based on NewEdge Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.